Murepavadin TFA

CAS No. ———

Murepavadin TFA( ——— )

Catalog No. M40532 CAS No. ———

Murepavadin (TFA) is a 14-amino acid cyclic peptide that is a potent, specific antibiotic used to treat bacterial infections caused by Pseudomonas aeruginosa.Murepavadin (TFA) targets the LPS transporter portin D.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Murepavadin TFA
  • Note
    Research use only, not for human use.
  • Brief Description
    Murepavadin (TFA) is a 14-amino acid cyclic peptide that is a potent, specific antibiotic used to treat bacterial infections caused by Pseudomonas aeruginosa.Murepavadin (TFA) targets the LPS transporter portin D.
  • Description
    Murepavadin (TFA) is a 14-amino acid cyclic peptide that is a potent, specific antibiotic used to treat bacterial infections caused by Pseudomonas aeruginosa.Murepavadin (TFA) targets the LPS transporter portin D.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    ———
  • Formula Weight
    ———
  • Molecular Formula
    ———
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Citronellal

    Citronellal is a monoterpene predominantly formed by the secondary metabolism of plants producing antithrombotic antiplatelet and antihypertensive activities.

  • Stacofylline

    Stacofylline is a xanthine derivative that is used to treat migraine headaches.

  • Vipivotide tetraxeta...

    Vipivotide tetraxetan is a high potent inhibitor of prostate-specific membrane antigen (PSMA)(Ki of 0.37 nM).